Higher body weight in Chinese patients is associated with treatment resistance to fixed-dose interleukin-17 inhibition with ixekizumab but not to weight-adjusted secukinumab therapy

View at publisher
Authors: Ying Li, Yuxiong Jiang, Biao Ma, Yifan Hu, Min Dai, Dawei Huang, Yu Wang, Yangfeng Ding, Yuling Shi
Cited by: 0
References: 5

Fields of Study & Subjects

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Skin Diseases and Diabetes

Publication details

Journal / source
Journal of the American Academy of Dermatology
Volume
94
Issue
6
Pages
1774–1777
Publication date
23 February 2026
Language
EN